RNA Clinical Trials Resources

  1. Location Considerations For Successful Clinical Trials 9/12/2023

    Consider the advantages associated with conducting early- to late-phase clinical trials in China and the broader APAC region, as well as potential challenges that could impact the trial process and patient outcomes

  2. Non-Hodgkin Lymphoma – Global Clinical Trial Landscape - Focus On Asia Pacific 9/12/2023

    Gain a better understanding of the global clinical trial landscape of Non-Hodgkin lymphoma (NHL) and its trends in the Asia Pacific.

  3. Liver Cancer – Global Clinical Trial Landscape - Focus On Asia Pacific 9/11/2023

    Unearth how health officials are preparing to meet the rising demand for resources regarding liver cancer and ensure effective management throughout the cancer pathway.

  4. Head and Neck Cancer – Global Clinical Trial Landscape - Focus On Asia Pacific 9/11/2023

    Get a full overview of the current clinical trial landscape as it relates to HNC and where treatment efforts are headed in the future.

  5. Staying On Top Of Changing FDA Regulations To Avoid Clinical Holds 8/14/2023

    As the biotech industry has grown exponentially, so has the number of FDA clinical holds. Biotech companies need strategic planning to avoid or quickly resolve costly clinical holds.

  6. The Future Is Now: CGT Innovation, Challenges, And Perspectives 7/19/2023

    As CGTs advance toward clinical trials, developers face a number of challenges such as navigating a shifting regulatory landscape and employing beneficial manufacturing processes.

  7. Advancing Cell And Gene Therapy Clinical Development In 2023 7/19/2023

    Examine considerations on bringing together the CMC and clinical teams early in the development process, promoting transparency and communication with regulators, and increasing patient access and diversity in clinical trials.

  8. Moving CGTx Clinical Development Forward In 2023 6/27/2023

    Gain insights on cell and gene therapy (CGTx) clinical trial design and commercialization strategies as a panel of industry experts share their considerations.

  9. Expectations On The Pathway To GMP For Gene-Modified Cell Therapies 6/21/2023

    Learn how a robust understanding of the RNP’s critical process parameters and CQAs is crucial for ensuring product consistency, enhancing patient safety, and maintaining regulatory compliance.

  10. RNA Therapies – Global Clinical Trial Landscape - Focus On Asia Pacific 5/17/2023

    Learn about the global clinical trial landscape of RNA therapy, with emphasis on trends in the Asia Pacific, and recent advancements in the field.